Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Annalisa Ruggeri and Fabio Ciceri.
Annalisa Ruggeri
Connection Strength
3.750
Fabio Ciceri
  1. Trend towards reduction in COVID-19 in-hospital mortality. Lancet Reg Health Eur. 2021 Apr; 3:100059.
    View in: PubMed
    Score: 0.931
  2. Decreased in-hospital mortality in patients with COVID-19 pneumonia. Pathog Glob Health. 2020 09; 114(6):281-282.
    View in: PubMed
    Score: 0.222
  3. Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy. Clin Immunol. 2020 08; 217:108509.
    View in: PubMed
    Score: 0.222
  4. Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study. Eur J Intern Med. 2020 06; 76:43-49.
    View in: PubMed
    Score: 0.221
  5. The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Clin Immunol. 2020 06; 215:108450.
    View in: PubMed
    Score: 0.220
  6. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. 2020 04 15; 22(2):95-97.
    View in: PubMed
    Score: 0.219
  7. Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMT. Bone Marrow Transplant. 2019 12; 54(12):1987-1994.
    View in: PubMed
    Score: 0.206
  8. Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide. Cancer. 2018 04 01; 124(7):1428-1437.
    View in: PubMed
    Score: 0.188
  9. Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study. Nutr Metab Cardiovasc Dis. 2021 06 30; 31(7):2156-2164.
    View in: PubMed
    Score: 0.059
  10. Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation. Front Immunol. 2021; 12:675678.
    View in: PubMed
    Score: 0.059
  11. Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study. Lancet Rheumatol. 2021 Apr; 3(4):e253-e261.
    View in: PubMed
    Score: 0.058
  12. Pulmonary Vascular Thrombosis in COVID-19 Pneumonia. J Cardiothorac Vasc Anesth. 2021 Dec; 35(12):3631-3641.
    View in: PubMed
    Score: 0.058
  13. Biobanking for COVID-19 research. Panminerva Med. 2020 Oct 19.
    View in: PubMed
    Score: 0.057
  14. Integrated clinical role of echocardiography in patients with COVID-19. Heart. 2020 12; 106(23):1864-1865.
    View in: PubMed
    Score: 0.057
  15. Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy. Clin Immunol. 2020 11; 220:108598.
    View in: PubMed
    Score: 0.056
  16. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc. 2020 Sep; 22(3):200-211.
    View in: PubMed
    Score: 0.056
  17. Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19. Heart. 2020 09; 106(17):1324-1331.
    View in: PubMed
    Score: 0.056
  18. Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study. Ann Rheum Dis. 2020 10; 79(10):1277-1285.
    View in: PubMed
    Score: 0.056
  19. GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study. Lancet Rheumatol. 2020 Aug; 2(8):e465-e473.
    View in: PubMed
    Score: 0.055
  20. Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2021 03; 56(3):532-535.
    View in: PubMed
    Score: 0.055
  21. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020 Jun; 2(6):e325-e331.
    View in: PubMed
    Score: 0.055
  22. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc. 2020 Apr 23.
    View in: PubMed
    Score: 0.055
  23. Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency Crit Care Resusc. 2020 04 01; 22(2):91-94.
    View in: PubMed
    Score: 0.055
  24. Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT. Bone Marrow Transplant. 2019 09; 54(9):1499-1510.
    View in: PubMed
    Score: 0.050
  25. Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission. Am J Hematol. 2018 10; 93(10):1236-1244.
    View in: PubMed
    Score: 0.049
  26. Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2019 04; 54(4):519-530.
    View in: PubMed
    Score: 0.049
  27. Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP. Bone Marrow Transplant. 2018 09; 53(9):1201-1205.
    View in: PubMed
    Score: 0.048
  28. Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT. J Hematol Oncol. 2018 04 16; 11(1):55.
    View in: PubMed
    Score: 0.048
  29. Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study. Am J Hematol. 2018 06; 93(6):769-777.
    View in: PubMed
    Score: 0.048
  30. T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT). Cancer. 2018 05 15; 124(10):2142-2150.
    View in: PubMed
    Score: 0.047
  31. Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica. 2017 11; 102(11):1810-1822.
    View in: PubMed
    Score: 0.046
  32. The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis. Blood Adv. 2017 Apr 25; 1(11):669-680.
    View in: PubMed
    Score: 0.045
  33. Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1. Blood Adv. 2017 Feb 28; 1(7):477-485.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.